Widespread pulmonary endometriosis 25 years after surgical menopause. A case report

Abstract

We herein present a clinical case of widespread pulmonary endometriosis in a 65-year-old woman 25 years after surgical menopause. The patient is known from the history to have had widespread genital and extragenital endometriosis involving the ureters. Conspicuous is the fact that menopausal hormone therapy was not prescribed, which could account for the recurrence of the disease. However, the presence of extragenital endometriosis lesions in the lungs and an infiltrate in the pelvis may indicate reactivation of the disease. Taking into account the altered metabolism of estrogens in the endometriosis implants and the low level of estradiol in peripheral blood, the use of aromatase inhibitors may be a strategy for the treatment of common forms of endometriosis, including extragenital one, in the postmenopausal period.

Keywords

endometriosis / surgical menopause / extragenital endometriosis / aromatase inhibitors

References

[1] Yarmolinskaya MI, Aylamazyan EK. Genital’nyy endometrioz. Razlichnye grani problemy. Saint Petersburg: Eko-Vektor; 2017. (In Russ.)

[2] Ярмолинская М.И., Айламазян Э.К.Генитальный эндометриоз. Различные грани проблемы. Санкт-Петербург: Эко-Вектор, 2017. 615 с.

[3] Rosa-e-Silva JC, Carvalho BR, Barbosa HdeF, et al. Endometriosis in postmenopausal women without previous hormonal therapy: report of three cases. Climacteric. 2008;11(6):525–528. DOI: 10.1080/13697130802490256

[4] Rosa-e-Silva J.C., Carvalho B.R., Barbosa H de F., et al. Endometriosis in postmenopausal women without previous hormonal therapy: report of three cases // Climacteric. 2008. Vol.11. No. 6. P. 525–528. DOI: 10.1080/13697130802490256

[5] Morotti M, Remorgida V, Venturini PL, et al. Endometriosis in menopause: a single institution experience. Arch Gynecol Obstet. 2012;286(6):1571–1575. DOI: 10.1007/s00404-012-2473-5

[6] Morotti M., Remorgida V., Venturini P.L., et al. Endometriosis in menopause: a single institution experience // Arch. Gynecol. Obstet. 2012. Vol. 286. No. 6. P. 1571–1575. DOI: 10.1007/s00404-012-2473-5

[7] Machairiotis N, Stylianaki A, Dryllis G, et al. Extrapelvic endometriosis: a rare entity or an under diagnosed condition? Diagn Pathol. 2013;8:194. DOI: 10.1186/1746-1596-8-194

[8] Machairiotis N., Stylianaki A., Dryllis G., et al. Extrapelvic endometriosis: a rare entity or an under diagnosed condition? // Diagn. Pathol. 2013. Vol. 8. P. 194. DOI: 10.1186/1746-1596-8-194

[9] Secosan C, Balulescu L, Brasoveanu S, et al. Endometriosis in menopause-renewed attention on a controversial disease. Diagnostics (Basel). 2020;10(3):134. DOI: 10.3390/diagnostics10030134

[10] Secosan C., Balulescu L., Brasoveanu S., et al. Endometriosis in menopause-renewed attention on a controversial disease // Diagnostics. 2020. Vol. 10. No. 3. P. 134. DOI: 10.3390/diagnostics10030134

[11] Bendon CL, Becker CM. Potential mechanisms of postmenopausal endometriosis. Maturitas. 2012;72(3):214–219. DOI: 10.1016/j.maturitas.2012.04.010

[12] Bendon C.L., Becker C.M. Potential mechanisms of postmenopausal endometriosis // Maturitas. 2012. Vol. 72. No. 3. P. 214–219. DOI: 10.1016/j.maturitas.2012.04.010

[13] Polyzos NP, Fatemi HM, Zavos A, et al. Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol. 2011;9:90. DOI: 10.1186/1477-7827-9-90

[14] Polyzos N.P., Fatemi H.M., Zavos A., et al. Aromatase inhibitors in post-menopausal endometriosis // Reprod. Biol. Endocrinol. 2011. Vol. 9. P. 90. DOI: 10.1186/1477-7827-9-90

[15] Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 1927;3(2):93–110.

[16] Sampson J.A. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation // Am. J. Pathol. 1927. Vol. 3. No. 2. P. 93–110.43.

[17] Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268–279. DOI: 10.1056/NEJMra0804690

[18] Bulun S.E. Endometriosis // N. Engl. J. Med. 2009. Vol. 360. No. 3. P. 268–279. DOI: 10.1056/NEJMra0804690

[19] Alifano M, Roth T, Broët SC, et al. Catamenial pneumothorax: a prospective study. Chest. 2003;124(3):1004–1008. DOI: 10.1378/chest.124.3.1004

[20] Alifano M., Roth T., Broët S.C., et al. Catamenial pneumothorax: a prospective study // Chest. 2003. Vol. 124. No. 3. P. 1004–1008. DOI: 10.1378/chest.124.3.1004

[21] Kovarik JL, Toll GD. Thoracic endometriosis with recurrent spontaneous pneumothorax. JAMA. 1966;196(6):595–597.

[22] Kovarik J.L., Toll G.D. Thoracic endometriosis with recurrent spontaneous pneumothorax // JAMA. 1966. Vol. 196. No. 6. P. 595–597.

[23] Ueki M. Histologic study of endometriosis and examination of lymphatic drainage in and from the uterus. Am J Obstet Gynecol. 1991;165(1):201–209. DOI: 10.1016/0002-9378(91)90252-m

[24] Ueki M. Histologic study of endometriosis and examination of lymphatic drainage in and from the uterus // Am. J. Obstet. Gynecol. 1991. Vol. 165. No. 1. P. 201–209. DOI: 10.1016/0002-9378(91)90252-m

[25] Pollacco J, Sacco K, Portelli M, et al. Molecular links between endometriosis and cancer. Gynecol Endocrinol. 2012;28(8):577–581. DOI: 10.3109/09513590.2011.650761

[26] Pollacco J., Sacco K., Portelli M., et al. Molecular links between endometriosis and cancer // Gynecol. Endocrinol. 2012. Vol. 28. No. 8. P. 577–581. DOI: 10.3109/09513590.2011.650761

[27] Kirshon B, Poindexter AN, Fast J. Endometriosis in multiparous women. J Reprod Med. 1989;34(3):215–217.

[28] Kirshon B., Poindexter A.N., Fast J. Endometriosis in multiparous women // J. Reprod. Med. 1989. Vol. 34. No. 3. P. 215–217.

[29] Borghese B, Zondervan KT, Abrao MS, et al. Recent insights on the genetics and epigenetics of endometriosis. Clin Genet. 2017;91(2):254–264. DOI: 10.1111/cge.12897

[30] Borghese B., Zondervan K.T., Abrao M.S., et al. Recent insights on the genetics and epigenetics of endometriosis // Clin. Genet. 2017. Vol. 91. No. 2. P. 254–264. DOI: 10.1111/cge.12897

[31] Bulun SE, Yang S, Fang Z, et al. Estrogen production and metabolism in endometriosis. Ann NY Acad Sci. 2002;955:75–406. DOI: 10.1111/j.1749-6632.2002.tb02767.x

[32] Bulun S.E., Yang S., Fang Z., et al. Estrogen production and metabolism in endometriosis // Ann. NY Acad. Sci. 2002. Vol. 955. P. 75–406. DOI: 10.1111/j.1749-6632.2002.tb02767.x

[33] Bulun SE, Sharda G, Rink J, et al. Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. J Clin Endocrinol Metab. 1996;81(3):1273–1277. DOI: 10.1210/jcem.81.3.8772611

[34] Bulun S.E., Sharda G., Rink J., et al. Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast // J. Clin. Endocrinol. Metab. 1996. Vol. 81. No. 3. P. 1273–1277. DOI: 10.1210/jcem.81.3.8772611

[35] Colette S, Lousse JC, Defrère S, et al. Absence of aromatase protein and mRNA expression in endometriosis. Hum Reprod. 2009;24(9):2133–2141. DOI: 10.1093/humrep/dep199

[36] Colette S., Lousse J.C., Defrère S., et al. Absence of aromatase protein and mRNA expression in endometriosis // Hum. Reprod. 2009. Vol. 24. No. 9. P. 2133–2141. DOI: 10.1093/humrep/dep199

[37] Zeitoun K, Takayama K, Sasano H, et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab. 1998;83(12):4474–4480. DOI: 10.1210/jcem.83.12.5301

[38] Zeitoun K., Takayama K., Sasano H., et al. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol // J. Clin. Endocrinol. Metab. 1998. Vol. 83. No. 2. P. 4474–4480. DOI: 10.1210/jcem.83.12.5301

[39] Andersson S, Moghrabi N. Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids. 1997;62(1):143–147. DOI: 10.1016/s0039-128x(96)00173-0

[40] Andersson S., Moghrabi N. Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases // Steroids. 1997. Vol. 62. No. 1. P. 143–147. DOI: 10.1016/s0039-128x(96)00173-0

[41] Satyaswaroop PG, Wartell DJ, Mortel R. Distribution of progesterone receptor, estradiol dehydrogenase, and 20 alpha-dihydroprogesterone dehydrogenase activities in human endometrial glands and stroma: progestin induction of steroid dehydrogenase activities in vitro is restricted to the glandular epithelium. Endocrinology. 1982;111(3):743–749. DOI: 10.1210/endo-111-3-743

[42] Satyaswaroop P.G., Wartell D.J., Mortel R. Distribution of progesterone receptor, estradiol dehydrogenase, and 20 alpha-dihydroprogesterone dehydrogenase activities in human endometrial glands and stroma: progestin induction of steroid dehydrogenase activities in vitro is restricted to the glandular epithelium // Endocrinology. 1982. Vol. 111. No. 3. P. 743–749. DOI: 10.1210/endo-111-3-743

[43] Delvoux B, Groothuis P, D’Hooghe T, et al. Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism. J Clin Endocrinol Metab. 2009;94(3):876–883. DOI: 10.1210/jc.2008-2218

[44] Delvoux B., Groothuis P., D’Hooghe T., et al. Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism // J. Clin. Endocrinol. Metab. 2009. Vol. 94. No. 3. P. 876–883. DOI: 10.1210/jc.2008-2218

[45] Mercorio A, Giampaolino P, Romano A, et al. Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism. Front Endocrinol. 2022;13. DOI: 10.3389/fendo.2022.950866

[46] Mercorio A., Giampaolino P., Romano A., et al. Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism // Front. Endocrinol. 2022. Vol. 13. DOI: 10.3389/fendo.2022.950866

[47] Klenov VE, Potretzke TA, Sehn JK, et al. Postmenopausal invasive endometriosis requiring supralevator pelvic exenteration. Obstet Gynecol. 2015;126(6):1215–1218. DOI: 10.1097/AOG.0000000000000998

[48] Klenov V.E., Potretzke T.A., Sehn J.K., et al. Postmenopausal invasive endometriosis requiring supralevator pelvic exenteration // Obstet. Gynecol. 2015. Vol. 126. No. 6. P. 1215–1218. DOI: 10.1097/AOG.0000000000000998

[49] Charatsi D, Koukoura O, Notavela IG, et al. Gastrointestinal and urinary tract endometriosis: a review on the commonest locations of extrapelvic endometriosis. Adv Med. 2018;2018. DOI: 10.1155/2018/3461209

[50] Charatsi D., Koukoura O., Notavela I.G., et al. Gastrointestinal and urinary tract endometriosis: a review on the commonest locations of extrapelvic endometriosis // Adv. Med. 2018. Vol. 2018. DOI: 10.1155/2018/3461209

[51] Choi SW, Lee HN, Kang SJ, et al A case of cutaneous endometriosis developed in postmenopausal woman receiving hormonal replacement. J Am Acad Dermatol. 1999;41(2 Pt 2):327–329. DOI: 10.1016/s0190-9622(99)70377-4

[52] Choi S.W., Lee H.N., Kang S.J., et al. A case of cutaneous endometriosis developed in postmenopausal woman receiving hormonal replacement // J. Am. Acad. Dermatol. 1999. Vol. 41. No. 2. Pt 2. P. 327–329. DOI: 10.1016/s0190-9622(99)70377-4

[53] Deval B, Rafii A, Felce Dachez M, et al. Sigmoid endometriosis in a postmenopausal woman. Am J Obstet Gynecol. 2002;187(6):1723–1725. DOI: 10.1067/mob.[phone]

[54] Deval B., Rafii A., Felce Dachez M., et al. Sigmoid endometriosis in a postmenopausal woman // Am. J. Obstet. Gynecol. 2002. Vol. 187. No. 6. P. 1723–1725. DOI: 10.1067/mob.[phone]

[55] Popoutchi P, dos Reis Lemos CR, Silva JC, et al. Postmenopausal intestinal obstructive endometriosis: case report and review of the literature. Sao Paulo Med J. 2008;126(3):190–193. DOI: 10.1590/s1516-31802008000300010

[56] Popoutchi P., dos Reis Lemos C.R., Silva J.C., et al. Postmenopausal intestinal obstructive endometriosis: case report and review of the literature // Sao Paulo Med. J. 2008. Vol. 126. No. 3. P. 190–193. DOI: 10.1590/s1516-31802008000300010

[57] Beuke M, Dahlem R, Fisch M. Distal stenosis of the ureter due to extrinsic endometriosis in a postmenopausal woman. Aktuelle Urol. 2006;37(2):143–144. DOI: 10.1055/s-2005-870933

[58] Beuke M., Dahlem R., Fisch M. Distale distal stenosis of the ureter due to extrinsic endometriosis in a postmenopausal woman // Aktuelle Urol. 2006. Vol. 37. No. 2. P. 143–144. DOI: 10.1055/s-2005-870933

[59] Pugliese JM, Peterson AC, Philbrick JH, et al. Ureteral endometriosis in patients after total abdominal hysterectomy: presentation and diagnosis: a case series. Urology. 2006;67(3). DOI: 10.1016/j.urology.2005.09.031

[60] Pugliese J.M., Peterson A.C., Philbrick J.H., et al. Ureteral endometriosis in patients after total abdominal hysterectomy: presentation and diagnosis: a case series // Urology. 2006. Vol. 67. No. 3. DOI: 10.1016/j.urology.2005.09.031

[61] Goldsmith PJ, Ahmad N, Dasgupta D, et al. Case hepatic endometriosis: a continuing diagnostic dilemma. HPB Surg. 2009;2009. DOI: 10.1155/2009/407206

[62] Goldsmith P.J., Ahmad N., Dasgupta D., et al. Case hepatic endometriosis: a continuing diagnostic dilemma // HPB Surg. 2009. Vol. 2009. DOI: 10.1155/2009/407206

[63] Yarmolinskaya MI, Rusina EI, Semenova VO, et al. Extragenital endometriosis: diagnostic difficulties, modern treatment policy. Obstetrics and Gynecology. 2022;(8):154–162. (In Russ.). DOI: 10.18565/aig.2022.8.154-162

[64] Ярмолинская М.И., Русина Е.И., Семенова В.О., и др. Экстрагенитальный эндометриоз: сложности диагностики, современная тактика лечения // Акушерство и гинекология. 2022. № 8. C. 154–162. DOI: 10.18565/aig.2022.8.154-162

[65] Gemmell LC, Webster KE, Kirtley S, et al. The management of menopause in women with a history of endometriosis: a systematic review. Hum Reprod Update. 2017;23(4):481–500. DOI: 10.1093/humupd/dmx011

[66] Gemmell L.C., Webster K.E., Kirtley S., et al. The management of menopause in women with a history of endometriosis: a systematic review// Hum. Reprod. Update. 2017. Vol. 23. No. 4. P. 481–500. DOI: 10.1093/humupd/dmx011

[67] Brodowska A, Brodowski J, Laszczyńska M, et al. Immunoexpression of aromatase cytochrome P450 and 17β-hydroxysteroid dehydrogenase in women’s ovaries after menopause. J Ovarian Res. 2014;7:52. DOI: 10.1186/1757-2215-7-52

[68] Brodowska A., Brodowski J., Laszczyńska M., et al. Immunoexpression of aromatase cytochrome P450 and 17β-hydroxysteroid dehydrogenase in women’s ovaries after menopause // J. Ovarian Res. 2014. Vol. 7. P. 52. DOI: 10.1186/1757-2215-7-52

[69] Attar E, Bulun SE. Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update. 2006;12(1):49–56. DOI: 10.1093/humupd/dmi034

[70] Attar E., Bulun S.E. Aromatase and other steroidogenic genes in endometriosis: translational aspects // Hum. Reprod. Update. 2006. Vol. 12. No. 1. P. 49–56. DOI: 10.1093/humupd/dmi034

[71] Noble LS, Simpson ER, Johns A, et al. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996;81(1):174–179. DOI: 10.1210/jcem.81.1.8550748

[72] Noble L.S., Simpson E.R., Johns A., et al. Aromatase expression in endometriosis // J. Clin. Endocrinol. Metab. 1996. Vol. 81. No. 1. P. 174–179. DOI: 10.1210/jcem.81.1.8550748

[73] Soliman NF, Hillard TC. Hormone replacement therapy in women with past history of endometriosis. Climacteric. 2006;9(5):325–335. DOI: 10.1080/13697130600868711

[74] Soliman N.F., Hillard T.C. Hormone replacement therapy in women with past history of endometriosis // Climacteric. 2006. Vol. 9. No. 5. P. 325–335. DOI: 10.1080/13697130600868711

[75] Takayama K, Zeitoun K, Gunby RT, et al. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril. 1998;69(4):709–713. DOI: 10.1016/s0015-0282(98)00022-3

[76] Takayama K., Zeitoun K., Gunby R.T., et al. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor // Fertil. Steril. 1998. Vol. 69. No. 4. P. 709–713. DOI: 10.1016/s0015-0282(98)00022-3

[77] Słopień R, Męczekalski B. Aromatase inhibitors in the treatment of endometriosis. Prz Menopauzalny. 2016;15(1):43–47. DOI: 10.5114/pm.2016.58773

[78] Słopień R., Męczekalski B. Aromatase inhibitors in the treatment of endometriosis // Prz. Menopauzalny. 2016. Vol. 15. No. 1. P. 43–47. DOI: 10.5114/pm.2016.58773

[79] Pavone ME, Bulun SE. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril. 2012;98(6):1370–1379. DOI: 10.1016/j.fertnstert.2012.08.053

[80] Pavone M.E., Bulun S.E. Aromatase inhibitors for the treatment of endometriosis // Fertil. Steril. 2012. Vol. 98. No. 6. P. 1370–1379. DOI: 10.1016/j.fertnstert.2012.08.053

[81] Endometriosis. Guideline of European Society of Human Reproduction and Embryology. 2022 [cited 2023 Aug 12]. Available from: https://www.bsge.org.uk/wp-content/uploads/2022/02/ESHRE-GUIDELINE-ENDOMETRIOSIS-2022.pdf

[82] Endometriosis. Guideline of European Society of Human Reproduction and Embryology. 2022 [дата обращения 12.08.2023]. Доступ по ссылке: https://www.bsge.org.uk/wp-content/uploads/2022/02/ESHRE-GUIDELINE-ENDOMETRIOSIS-2022.pdf

[83] Patent RUS 2013152127/15 / 10.02.2015. Byul. No. 4 Yarmolinskaya MI, Molotkov AS, Bezhenar’ VF. Sposob kompleksnogo lecheniya naruzhnogo genital’nogo endometrioza. (In Russ.) [cited 2023 Aug 12]. Available from: https://rusneb.ru/catalog/000224_000128_0002541089_20150210_C1_RU/

[84] Патент РФ на изобретение 2013152127/15 / 10.02.2015. Бюл. № 4 Ярмолинская М.И., Молотков А.С., Беженарь В.Ф. Способ комплексного лечения наружного генитального эндометриоза. дата обращения 12.08.2023]. Доступ по ссылке: https://rusneb.ru/catalog/000224_000128_0002541089_20150210_C1_RU/

RIGHTS & PERMISSIONS

Eсо-Vector